Newbury Park, CA, United States of America

Brian Stonecipher

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 5.3

ph-index = 12

Forward Citations = 583(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: The Innovative Journey of Brian Stonecipher

Introduction

Brian Stonecipher, a distinguished inventor based in Newbury Park, California, holds an impressive portfolio of 24 patents. His contributions to the field of drug delivery systems reflect a commitment to enhancing patient experiences and improving healthcare technologies.

Latest Patents

Among his latest innovations, Stonecipher has developed hybrid drug delivery devices designed with a grip portion to enhance usability and stability. These devices feature a unique cap with a release liner, allowing users to expose the grip portion with ease. Additionally, the devices include a retractable needle guard that enhances safety while ensuring that the grip portion wraps around it, further adding to the functionality and design of drug delivery systems.

Career Highlights

Brian Stonecipher is currently employed at Amgen Inc., a renowned biotechnology company. His work focuses on advancing drug delivery technologies, positioning the organization at the forefront of medical innovations. His extensive patent portfolio showcases his dedication to creating solutions that address real-world healthcare challenges.

Collaborations

Stonecipher collaborates with talented professionals, including Masamichi Udagawa and Laurie Martin Burns, who contribute to his innovative projects. This teamwork underscores the importance of collaboration in the advancement of biotechnology and drug delivery systems.

Conclusion

Brian Stonecipher's contributions to the field of health technology through his inventive patents play a crucial role in transforming drug delivery methods. His innovative spirit and dedication to improving patient experiences through advanced designs continue to pave the way for future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…